About Infraredx
Infraredx is a Healthcare company based in Burlington (United States) founded in 1998, and was acquired by Nipro in September 2015. Coronary imaging and plaque detection system. Infraredx has raised $99.99 million across 13 funding rounds from investors including Nipro Corporation, GE Healthcare Equipment Finance and Sanderling Ventures. Infraredx offers products and services including Clarispro® HD-IVUS, Dualpro® IVUS+ NIRS, Makoto® Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Screening Devices. Its legal entity is Infraredx, Inc. Its competitors include Ionetix, Cleveland HeartLab and POINT Biomedical; 3 of its 3 listed competitors have raised funding.
Company details
Infraredx was founded in 1998 in Burlington, United States, within the medical devices sector. Near-infrared spectroscopic technology is utilized to design and manufacture catheter-based systems for coronary artery imaging. Plaque composition is assessed through fiber-optic NIR spectroscopy, with FDA clearance secured for detecting lipid core plaques. The product range encompasses the LipiScan NIR Coronary Imaging System, LipiScan IVUS Coronary Imaging System, and TVC Imaging System for evaluating vessel structure.
- Total Equity Funding$99.99M (USD)
in 13 rounds
- Latest Funding Round$20M (USD), Debt – Conventional
Nov 2013
- InvestorsNipro Corporation
& 2 more
- Acquired byNipro
(Sep 2015)
Products & Services of Infraredx
Infraredx offers a comprehensive portfolio of products and services, including Clarispro® HD-IVUS, Dualpro® IVUS+ NIRS, Makoto® Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector.
Delivers high-resolution visualization of vessel structures for accurate diagnosis.
Identifies lipid-core plaques to predict and prevent cardiac events.
Combines technologies for comprehensive insights into vascular conditions.
Supports procedures with controlled inflation for imaging applications.
Facilitates multi-device access during intravascular procedures.
Apps and channels of Infraredx
its YouTube channel Infraredx has 119 subscribers and 30 videos.
Videos from Infraredx
The most watched videos on Infraredx's YouTube channel, Infraredx (119 subscribers). Click a video to play it here.
More on Infraredx.
Funding Insights of Infraredx
Infraredx has successfully raised a total of $99.99M across 13 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $99.99M
- Total Rounds 13
- Last Round Debt – Conventional — $20M
- First Round $3.53M
(Aug 2002)
- Investors Count 3
Latest 10 of 13 funding rounds of Infraredx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2013 | $20M | Debt – Conventional | – | – | |
| Aug 2013 | $25M | Series C | – | – | |
| Dec 2011 | $10M | Debt – Conventional | – | – | |
| Jun 2011 | $24.16M | Series C | – | – | – |
| Oct 2010 | $21.31M | Series C | – | Sanderling Ventures | – |
| Jul 2010 | $1.53M | Series B | – | – | – |
| Jan 2010 | $10M | Series B | – | – | – |
| Aug 2008 | $7.3M | Series B | – | – | – |
| Jun 2005 | $2.8M | Series A | – | – | – |
| Mar 2005 | $250,000 | Debt – Convertible | – | – | – |
3 investors in total: 3 institutional.
Investors in Infraredx
Infraredx has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Nipro Corporation, GE Healthcare Equipment Finance and Sanderling Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biomedical investment financing and active management services. | sanderling.com | |||
Offers flexible financing and risk-sharing for healthcare industry assets globally. | 2015 | gehcfinance.com | Boston, United States | |
Manufacturer of medical devices, pharmaceuticals, and regenerative medicine products | 1954 | nipro.co.jp | Osaka, Japan |
Investor details for Infraredx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Infraredx
4 dated milestones of Infraredx across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Infraredx is founded.
- Funding First funding round of $3.5M.
- Funding Latest funding round, Debt – Conventional, of $20.0M.
- Exit Acquired by Nipro.
Competitors of Infraredx
Infraredx has 3 listed competitors in our database, 3 of them funded. They include Ionetix, Cleveland HeartLab and POINT Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ionetix.com | 2009 | San Francisco, United States | $61.08M | Superconducting cyclotrons for PET radioisotopes are developed by Ionetix. | ||
| clevelandheartlab.com | 2008 | Cleveland, United States | $38.85M | Cardiovascular biomarkers are utilized for disease prevention and management. | ||
| pointbio.com | 1996 | San Carlos, United States | $56.4M | Offers a product for cardiologists to conduct myocardial perfusion imaging studies. |
Detailed competitors of Infraredx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Infraredx
The website of Infraredx (infraredx.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 6.8% vs previous month
Websites whose visitors overlap most with Infraredx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dicardiology.com | 100% | 79.8K | #510,652 | View details | |
| ninepointmedical.com | 87% | View details | |||
| medtech.org | 87% | View details | |||
medtechcon.com | medtechcon.com | 87% | – | ||
| sequanamedical.com | 53% | 10.2K | #2,174,640 | View details |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Infraredx (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Infraredx
Complete news archive for Infraredx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infraredx
Infraredx was founded in 1998 and raised its 1st funding round 4 years after it was founded.
Infraredx is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
Infraredx is a funded company, having raised a total of $99.99M across 13 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $250K, raised on Aug 2002.
Infraredx was founded in 1998 in Burlington, United States, within the medical devices sector. Near-infrared spectroscopic technology is utilized to design and manufacture catheter-based systems for coronary artery imaging. Plaque composition is assessed through fiber-optic NIR spectroscopy, with FDA clearance secured for detecting lipid core plaques. The product range encompasses the LipiScan NIR Coronary Imaging System, LipiScan IVUS Coronary Imaging System, and TVC Imaging System for evaluating vessel structure.
Infraredx's top competitors include Ionetix, Cleveland HeartLab and POINT Biomedical.
Infraredx offers Clarispro® HD-IVUS, Dualpro® IVUS+ NIRS, Makoto® Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector.
Infraredx has 3 investors. Key investors include Nipro Corporation, GE Healthcare Equipment Finance, and Sanderling Ventures.
Infraredx operates through Infraredx, Inc..
Yes. Infraredx was acquired by Nipro in September 2015.